Events

Apply Here The Mary Kay Ash Foundation is a non-profit public foundation, which focuses on funding research for innovative grants for translational research of cancers affecting women (ovarian, uterine, breast, endometrial or cervical cancer among others). Translational research is broadly defined as research that will provide a scientific link between laboratory research and the clinic. Such research would lead to improvement in diagnosis, prognosis, prevention, or treatment of the cancer.   Grants will be awarded in the amount of $100,000 over a two-year period. HICCC has bee invited to submit one grant proposal.   Potential nominees must meet the following eligibility criteria: The Principal Investigator must be a full-time Assistant Professor or higher at the time of application submission Staff scientists, postdoctoral trainees and instructors are NOT eligible up to one co-PI is permitted. International co-PIs are permitted with the caveat that all funds will be designated to the U.S.-based university. U.S. citizenship is not a requirement. The total budget may not exceed $100,000 (combined indirect/direct costs); equipment and travel costs must be justified; Indirect costs can’t exceed 15% of the direct costs total Previous years grant recipients are eligible to apply as long as they are not currently receiving funding from the foundation   To be considered, eligible faculty should submit: Summary (1-page) of the proposed outlining the proposed research, specific aims and objectives, innovation and significance References cited in the summary (not counted toward the page limit) NIH-formatted Biosketch (new format) List of Current and Pending Grants Submitted applications will be reviewed by the HICCC Pilot Grant Committee. Review criteria include: the scientific merit of the application, and strength of the applicant. Internal HICCC application deadline: Friday, January 7, 2022 5:00 pm Submit application here. External Mary Kay Foundation application deadline: Tuesday, February 4, 2022.

Damon Runyon Clinical Investigator Award Internal Competition The Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine. The Clinical Investigator Award program is specifically intended to provide outstanding young physicians with the resources and training structure essential to becoming successful clinical investigators. The goal is to increase the number of physicians capable of moving seamlessly between the laboratory and the patient’s bedside in search of breakthrough treatments. Each applicant must be nominated by their institution. HICCC can nominate up to 5 applicants.  To apply for the nomination, applicants must provide the following documents using the InfoReady portal here. a one-page research summary NIH-formatted biosketch (new format) mentor's training proposal  mentor's letters of support External application deadline: February 1, 2022 For more details on eligibility, click here: Clinical Investigator Award

THE DEAN'S LECTURE SERIES The 43rd Alexander Ming Fisher Lecture “A Story of Communication Skills in the COVID Context: using, developing, teaching, inspiring” presented by Monica L. Lypson, MD, MHPE Rolf H. Scholdager Professor of Medicine at CUMC Vice Dean for Education, Vagelos College of Physicians & Surgeons  Columbia University President, Society of General Internal Medicine This activity has been approved for AMA PRA Category 1 Credit ™ Tuesday, November 30, 2021 at 4:30 p.m.  Guests may attend the lecture in-person or virtually on Zoom.    Attend in-person: CU affiliates with green passes only  Vagelos Education Center 104 Haven Avenue, 4th Floor Room 401 Registration is not required to attend in-person - or - Register to attend virtually on Zoom webinar: for non CU affiliates and others that cannot attend in person.   More information on the Alexander Ming Fisher Lecture Read Dr. Lypson's Biography  

Laura J. Niedernhofer, MD, PhD Director, Institute of the Biology of Aging and Metabolism Medical Discovery Team Biology of Aging Professor Biochemistry, Molecular Biology & Biophysics      University of Minnesota, School of Medicine Therapeutically targeting senescent cells to treat age-related diseases To join please click here Meeting ID: 996 9280 3838 Passcode: 762015